Random forest-based modelling to detect biomarkers for prostate cancer progression
2019 · Clinical Epigenetics · 134 citations
https://doi.org/10.1186/s13148-019-0736-8
S
Sören Weidemann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
2.3K
Citations
27
h-index
63
i10-index
Sören Weidemann is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Liver Diseases and Immunity & Cancer Immunotherapy and Biomarkers & Liver Disease Diagnosis and Treatment. The author has an h-index of 27, co-authored 173 publications.
ORCID: 0000-0001-7037-3265Papers by this author
worksMesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
2021 · Biomedicines · 89 citations
https://doi.org/10.3390/biomedicines9040397
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors
2021 · Biomarker Research · 63 citations
https://doi.org/10.1186/s40364-021-00299-4
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms
2020 · Cellular Oncology · 47 citations
https://doi.org/10.1007/s13402-020-00496-7
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
2022 · Journal of Hepatology · 32 citations
https://doi.org/10.1016/j.jhep.2022.07.019
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
2021 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 21 citations
https://doi.org/10.1007/s00428-021-03204-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat